PTC Therapeutics
PTCT
#2691
Rank
A$9.34 B
Marketcap
A$112.63
Share price
0.57%
Change (1 day)
44.92%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: A$9.34 Billion

As of June 2026 PTC Therapeutics has a market cap of A$9.34 Billion. This makes PTC Therapeutics the world's 2691th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$9.34 B-0.79%
2025A$9.41 B67.91%
2024A$5.60 B83.72%
2023A$3.05 B-25.42%
2022A$4.09 B5.39%
2021A$3.88 B-28.28%
2020A$5.41 B27.47%
2019A$4.24 B72.34%
2018A$2.46 B178.12%
2017A$0.88 B70.66%
2016A$0.51 B-65.57%
2015A$1.50 B-27.52%
2014A$2.08 B359.54%
2013A$0.45 B

End of Day market cap according to different sources

On Jun 18th, 2026 the market cap of PTC Therapeutics was reported to be:

A$9.34 Billion
by Nasdaq info icon info icon
A$9.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
A$400.22 B 4,183.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
A$163.46 B 1,649.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.33 B-85.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$2.63 B-71.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.34 B-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A$16.04 B 71.71%๐Ÿ‡บ๐Ÿ‡ธ USA